Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Mead

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Nature Cell Biology|January 19, 2016
A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitorsMario Buono, Raffaella Facchini, Sahoko Matsuoka, et al.
BMC Cancer|January 9, 2025
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trialGraham McIlroy, Charlotte Gaskell, Aimee Jackson, et al.
Blood|March 21, 2018
Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cellsWen Hao Neo, Christopher A G Booth, Emanuele Azzoni, et al.
British Journal of Haematology|April 1, 2015
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST TrialAdam J Mead, Dragana Milojkovic, Steven Knapper, et al.
The Journal of Experimental Medicine|September 14, 2017
Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional programStephen J Loughran, Federico Comoglio, Fiona K Hamey, et al.
Genome Biology|May 5, 2016
Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathwaysBethan Psaila, Nikolaos Barkas, Deena Iskander, et al.
JACC. Cardiooncology|September 6, 2024
Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors From the UK BiobankCeleste McCracken, Dorina-Gabriela Condurache, Liliana Szabo, et al.
Haematologica|February 1, 2020
The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remissionSandrine Jeanpierre, Kawtar Arizkane, Supat Thongjuea, et al.
British Journal of Haematology|November 28, 2018
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology GuidelineMary Frances McMullin, Claire N Harrison, Sahra Ali, et al.
British Journal of Haematology|November 15, 2018
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology GuidelineMary F F McMullin, Adam J Mead, Sahra Ali, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Nature Cell Biology|January 19, 2016
A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitorsMario Buono, Raffaella Facchini, Sahoko Matsuoka, et al.
BMC Cancer|January 9, 2025
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trialGraham McIlroy, Charlotte Gaskell, Aimee Jackson, et al.
Blood|March 21, 2018
Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cellsWen Hao Neo, Christopher A G Booth, Emanuele Azzoni, et al.
British Journal of Haematology|April 1, 2015
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST TrialAdam J Mead, Dragana Milojkovic, Steven Knapper, et al.
The Journal of Experimental Medicine|September 14, 2017
Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional programStephen J Loughran, Federico Comoglio, Fiona K Hamey, et al.
Genome Biology|May 5, 2016
Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathwaysBethan Psaila, Nikolaos Barkas, Deena Iskander, et al.
JACC. Cardiooncology|September 6, 2024
Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors From the UK BiobankCeleste McCracken, Dorina-Gabriela Condurache, Liliana Szabo, et al.
Haematologica|February 1, 2020
The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remissionSandrine Jeanpierre, Kawtar Arizkane, Supat Thongjuea, et al.
British Journal of Haematology|November 28, 2018
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology GuidelineMary Frances McMullin, Claire N Harrison, Sahra Ali, et al.
British Journal of Haematology|November 15, 2018
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology GuidelineMary F F McMullin, Adam J Mead, Sahra Ali, et al.
Pageof 13